Skip to content
StockMarketAgent
Sector pending / Medical, Dental, and Hospital Equipment and SuppliesUpdated 2026-05-10 22:07 UTC

FRA/S5YA stock hub

FRA/S5YA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/S5YAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
20.2B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/S5YA
In the news

Latest news · FRA/S5YA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E40.2
P25 n/aP50 n/aP75 n/a
Trailing P/E59.2
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC9.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/S5YA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
173
Groups with data
11
Currency
AUD
Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

14
MetricValue
Country
Australia
Country code
DE
Enterprise value
EUR 21.3B
Exchange
Frankfurt Stock Exchange
Financial currency
AUD
First seen
2026-05-10
Industry
Medical, Dental, and Hospital Equipment and Supplies
Last refreshed
2026-05-10
Market cap
EUR 20.2B
Price
EUR 1.71
Price currency
EUR
Sic
5047
Symbol
fra/S5YA
Website
https://sigmahealthcare.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
1.69%
EV Earnings
62.5x
EV/EBIT
37.5x
EV/EBITDA
34.55x
EV/FCF
85.07x
EV/Sales
3.63x
FCF yield
1.24%
Forward P/E
40.17x
P/B ratio
7.26x
P/E ratio
59.18x
P/S ratio
3.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
EBIT Margin
9.34%
EBITDA Margin
9.78%
FCF margin
4.62%
Gross margin
18.55%
Gross Profit
EUR 1B
Gross Profit Growth
92.96%
Net Income
EUR 340.8M
Net Income Growth
97.09%
Pretax Margin
8.84%
Profit Margin
6.28%
Roa5y
9.48
ROCE
13.22
Roe5y
64.65
ROIC
9.36
Roic5y
19.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

5
MetricValue
Cagr1y
4.86%
EPS Growth
-72.86
FCF Growth
1.91%
OCF Growth
9.64%
Revenue Growth
208.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Assets
EUR 5B
Cash
EUR 91.2M
Current Assets
EUR 2B
Current Liabilities
EUR 1.2B
Debt
EUR 1.1B
Debt EBITDA
EUR 2.06
Debt Equity
EUR 0.41
Debt FCF
EUR 4.54
Equity
EUR 2.8B
Interest Coverage
7.54
Liabilities
EUR 2.2B
Long Term Assets
EUR 2.9B
Long Term Liabilities
EUR 958.8M
Net Cash
EUR -1B
Net Cash By Market Cap
EUR -5.19
Net Debt EBITDA
EUR 1.97
Net Debt Equity
EUR 0.38
Net Debt FCF
EUR 4.18
Tangible Book Value
EUR 590.9M
Tangible Book Value Per Share
EUR 0.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
1.67
Net Working Capital
EUR 778.5M
Quick ratio
1.08
Working Capital
EUR 755.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-627.02%
Dividend Growth
0%
Dividend Growth Years
2%
Dividend per share
EUR 0.02
Dividend Years
3
Dividend Yield
1.1%
Ex Div Date
2026-03-04
Last Dividend
EUR 0.01
Payout Frequency
Annual
Payout Ratio
81.13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

32
MetricValue
1Y total return
4.86%
200-day SMA
1.64
50-day SMA
1.63
50-day SMA vs 200-day SMA
50under200
All Time High
1.94
All Time High Change
-11.86%
All Time High Date
2025-02-18
All Time Low
1.5
All Time Low Change
14%
All Time Low Date
2025-04-07
ATR
0.02
Ch YTD
3.64
High
1.71
High52
1.83
High52 Date
2026-02-05
High52ch
-6.56%
Low
1.71
Low52
1.5
Low52 Date
2025-07-22
Low52ch
14%
Ma50ch
4.97%
Price vs 200-day SMA
4.01%
RSI
58.89
RSI Monthly
53.95
RSI Weekly
54.22
Sharpe ratio
0.12x
Sortino ratio
0.39
Total Return
-625.92%
Tr YTD
4.41
Tr1m
9.62%
Tr1w
0.59%
Tr3m
-4.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
EUR 506.4M
Operating Income Growth
107.9
Operating margin
9.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
6,465,969,976%
Net Borrowing
45,305,145.3
Shares Insiders
38.05%
Shares Institutions
9.86%
Shares Qo Q
0%
Shares Yo Y
627.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

53
MetricValue
Adjusted FCF
EUR 249.2M
Average Volume
0x
Bv Per Share
0.24
CAPEX
EUR -26.6M
Ch1m
9.62
Ch1w
0.59
Ch1y
3.64
Ch3m
-5
Change
-1.16%
Change From Open
0
Close
1.73
Days Gap
-1.16
Depreciation Amortization
25,688,738
Earnings Date
2026-05-15
EBIT
EUR 506.4M
EBITDA
EUR 530.2M
EPS
EUR 0.03
F Score
3
FCF
EUR 250.3M
FCF EV Yield
1.18x
Financing CF
-632,651,418
Fiscal Year End
June
Founded
1,912
Graham Number
0.39135
Graham Upside
-77.11
Income Tax
EUR 140.3M
Investing CF
158,744,450
Is Primary Listing
0
Last Earnings Date
2026-02-26
Last Report Date
2025-12-31
Ma150
1.66
Ma150ch
3.32%
Ma20
1.66
Ma20ch
2.95%
Net CF
-196,502,847
Next Earnings Date
2026-05-15
Open
1.71
P FCF Ratio
80.56
P OCF Ratio
72.81
Payment Date
2026-03-20
Ppne
346,487,460.2
Price Date
2026-05-08
Price EBITDA
EUR 38.04
Ptbv Ratio
34.13
Relative Volume
1,792.96x
Revenue
5,423,509,364x
SBC By Revenue
0.02x
Share Based Comp
1,124,844
Tax By Revenue
2.59x
Tax Rate
29.28%
Tr6m
0.75%
Volume
0
Z Score
6.55
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

FRA/S5YA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.1%
$0.02 annual per share
Payout ratio
+81.1%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
2 consecutive years of growth
Total shareholder yield
-625.9%
Next ex-dividend date: 2026-03-04
Performance

FRA/S5YA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+4.9%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/S5YA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+9.9%
Share of float held by funds and institutions
Insider ownership
+38.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+627.0%
Negative means the company is buying back shares.
Technical

FRA/S5YA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
58.9
Neutral momentum band
Price vs 200-day MA
+4.0%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.12
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/S5YA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/S5YA stock rating?

fra/S5YA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/S5YA analysis?

The full report lives at /stocks/fra/S5YA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/S5YA?

The latest report frames fra/S5YA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/S5YA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.